News
Videos
Conferences
Events
Resources
Subscribe

|Videos|October 15, 2020

Educated Patient® Prostate Cancer Summit: September 26, 2020

Author(s)CURE staff

View the full CURE® Educated Patient® Summit on Prostate Cancer here!

Episodes in this series

EP. 1 Educated Patient® Prostate Cancer Summit: September 26, 2020

EP. 1 Educated Patient® Prostate Cancer Summit: September 26, 2020

EP. 2 Educated Patient® Leukemia and Lymphoma Summit: October 27, 2020

EP. 2 Educated Patient® Leukemia and Lymphoma Summit: October 27, 2020

EP. 3 Educated Patient Multiple Myeloma Summit On-Demand: Nov. 21, 2020

EP. 3 Educated Patient Multiple Myeloma Summit On-Demand: Nov. 21, 2020

EP. 4 Educated Patient Lung Cancer Summit On-Demand: Dec. 12, 2020

EP. 4 Educated Patient Lung Cancer Summit On-Demand: Dec. 12, 2020

Educated Patient Women's Cancer Summit

EP. 5 Educated Patient Women's Cancers Summit: December 19, 2020

Watch the full CURE® Educated Patient® Summit on Prostate Cancer for an insightful discussion with multiple experts from the prostate cancer field. Topics covered from this summit include new treatment methods, dealing with side effects of treatment and much more!

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of man.

Prostate Cancer Diagnoses Rise as Death Rate Decline Slows

October 8th 2025

Image of man and doctor.

Active Surveillance or Treatment? Your Guide to Stage 1 Prostate Cancer Options

October 3rd 2025

FDA sign image

All FDA Oncology Approvals From September 2025

BySpencer Feldman

October 1st 2025

The FDA approved the denosumab biosimilars Enoby and Xtrenbo for patients on hormone therapies for breast or prostate cancer that weaken bones: © stock.adobe.com.

FDA Approves Enoby and Xtrenbo Biosimilars for Bone Health and Cancer Care

October 1st 2025

Patients with prostate cancer can position themselves to receive the best care possible by being seen by a multidisciplinary team of healthcare providers.

Why Multidisciplinary Care is Crucial in Prostate Cancer

September 29th 2025

Trending on CURE

What is the Importance of Recognizing Liver Cancer Awareness Month?

Patients With Cancer Urged to Ask Questions, Take Notes and Do Their Research

FDA OKs Breakthrough Therapy Designation to Sonrotoclax for MCL

Fruzaqla and Tyvyt Combo Shows Improved Outcomes in Advanced Kidney Cancer

Navigating Life’s Path With Multiple Myeloma

© 2025 MJH Life Sciences^®

All rights reserved.